Autonomic Nervous System: A Therapeutic Target for Cardiac End-Organ Damage in Hypertension

Lisa A Gottlieb1, Felix Mahfoud2, Stavros Stavrakis3

  • 1Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark (L.A.G., T.J., D.L.).

PubMed

Insights

Targeting the autonomic nervous system may treat hypertension and related heart damage. Interventions like beta-blockers and nerve stimulation show potential, but more clinical trials are needed to confirm effectiveness.

Area of Science:

  • Cardiology
  • Neuroscience
  • Hypertension Research

Background:

  • Arterial hypertension affects over 1.5 billion people globally, increasing risks of mortality and cardiovascular diseases like atrial fibrillation and heart failure.
  • The autonomic nervous system is crucial in hypertension development and progression, with factors like obesity and sleep apnea increasing sympathetic activity.
  • Hypertension exacerbates autonomic imbalance, creating conditions for atrial and ventricular damage.

Purpose of the Study:

  • To explore the potential of autonomic nervous system modulation in treating hypertension and associated cardiac end-organ damage.
  • To review interventions targeting the autonomic nervous system for managing hypertension and its cardiac complications.

Main Methods:

  • Literature review of studies on autonomic nervous system modulation for hypertension.
  • Discussion of interventions including pharmacological blockade, renal denervation, baroreceptor stimulation, vagal stimulation, and ganglionated plexus ablation.

Main Results:

  • Autonomic nervous system modulation presents a potential therapeutic strategy for preventing cardiac end-organ damage in hypertensive patients.
  • Various interventions targeting the autonomic nervous system are discussed for their potential benefits.

Conclusions:

  • Targeting the autonomic nervous system offers a promising approach to manage hypertension and prevent related atrial and ventricular damage.
  • There is a scarcity of clinical trials specifically evaluating the impact of autonomic modulation on hypertension-mediated cardiac end-organ damage.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
406
Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
590
Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
2.7K
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
381
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.0K
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
530